Nanomedicine: Nanotechnology, Biology and Medicine
Volume 6, Issue 5 , Pages 681-688, October 2010

Synthesis, characterization, and evaluation of antimicrobial and cytotoxic effect of silver and titanium nanoparticles

  • Fidel Martinez-Gutierrez, MSc

      Affiliations

    • Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, San Luis Potosí, México
  • ,
  • Peggy L. Olive, PhD

      Affiliations

    • British Columbia Research Centre, Vancouver, British Columbia, Canada
  • ,
  • Adriana Banuelos, PhD

      Affiliations

    • British Columbia Research Centre, Vancouver, British Columbia, Canada
  • ,
  • Erasmo Orrantia, PhD

      Affiliations

    • Centro de Investigaciones de Materiales Avanzados, Chihuahua, México
  • ,
  • Nereyda Nino, PhD

      Affiliations

    • Facultad de Ciencias, Universidad Autónoma de San Luis Potosí, San Luis Potosí, México
  • ,
  • Elpidio Morales Sanchez, PhD

      Affiliations

    • Departamento de Fisico Matematicas, Universidad Autónoma de San Luis Potosí, San Luis Potosí, México
  • ,
  • Facundo Ruiz, PhD

      Affiliations

    • Facultad de Ciencias, Universidad Autónoma de San Luis Potosí, San Luis Potosí, México
  • ,
  • Horacio Bach, PhD

      Affiliations

    • Department of Medicine, Division of Infectious Diseases, University of British Columbia, Vancouver, British Columbia, Canada
    • Corresponding Author InformationCorresponding author: Department of Medicine, Division of Infectious Diseases, University of British Columbia, 2733 Heather Street, Vancouver, British Columbia, Canada V5Z 3J5.
  • ,
  • Yossef Av-Gay, PhD

      Affiliations

    • Department of Medicine, Division of Infectious Diseases, University of British Columbia, Vancouver, British Columbia, Canada

Received 28 October 2009; accepted 2 February 2010. published online 08 March 2010.

Abstract 

Microbial resistance represents a challenge for the scientific community to develop new bioactive compounds. Nosocomial infections represent an enormous emerging problem, especially in patients with ambulatory treatment, which requires that they wear medical devices for an extended period of time. In this work, an evaluation of the antimicrobial activity of both silver and titanium nanoparticles was carried out against a panel of selected pathogenic and opportunistic microorganisms, some of them commonly associated with device-associated infections. Cytotoxicity assays monitoring DNA damage and cell viability were evaluated using human-derived monocyte cell lines. We show that silver-coated nanoparticles having a size of 20–25 nm were the most effective among all the nanoparticles assayed against the tested microorganisms. In addition, these nanoparticles showed no significant cytotoxicity, suggesting their use as antimicrobial additives in the process of fabrication of ambulatory and nonambulatory medical devices.

From the Clinical Editor

In this study, antimicrobial activity of silver and titanium nanoparticles was evaluated against a panel of selected pathogenic and opportunistic microorganisms. Silver-coated nanoparticles of 20–25 nm size were the most effective among all the nanoparticles without significant cytotoxicity, suggesting their use as antimicrobial additives in the process of fabrication of ambulatory and nonambulatory medical devices.

Key words: Silver nanoparticles, Titanium nanoparticles, Antimicrobial activity, Nanoparticle toxicity, DNA damage

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Funding for this studies at Y.A.’s laboratory was provided by the TB Veterans Charitable Foundation and Enox Biopharma Inc. Comet experiments were supported by the Canadian Cancer Society (P.L.O.).

PII: S1549-9634(10)00095-X

doi:10.1016/j.nano.2010.02.001

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 6, Issue 5 , Pages 681-688, October 2010